Introducing Sambria Pharmaceuticals' NeuroMed7

Sept. 3, 2014 - PRLog -- Sambria Pharmaceuticals is now in process of forming strategic alliances with aesthetic medicine device manufacturers and distributors to provide its topical anesthetic, NeuroMed7 to people having minimally invasive cosmetic procedures.

Prior to having procedures such as Botox, Dysport as well as micro-needling, LASER and a variety of other similar minimally invasive procedures, topical pain management creams are commonly applied several minutes prior to reduce the pain from these procedures. Sambria Pharmaceuticals currently offers its topical anesthetic, NeuroMed7 to patients receiving these procedures through medical device manufacturers and distributors who sell devices for cosmetic procedures. A cosmetic/aesthetic procedure is a procedure that aides in anti-aging of the facial skin that reduces lines, pigment, bags and a variety of other conditions that cause skin to look older as we age.

Sambria Pharmaceuticals currently also supplies NeuroMed7 to Medical Spas and Cosmetic Medicine clinics through its own sales force to be used and supplied to patients seeking minimally invasive aesthetic or cosmetic procedures.

The benefits to using Sambria Pharmaceuticals’ topical anesthetic is that is actually begins to work in only a few to several minutes as opposed to much longer, typically seen with competitive products. Sambria has developed a technology that allows the active ingredient, lidocaine HCL to absorb into the skin much faster than competitive topical anesthetics.

Sambria Pharmaceuticals’, NeuroMed7 is registered with the US FDA as an over-the-counter topical anesthetic medication that can legally be used without a prescription. NeuroMed7 can be used by doctors, aestheticians, nurses and physicians assistants who are licensed to perform minimally invasive aesthetic/cosmetic procedures.

More information about Sambria Pharmaceuticals’ NeuroMed7 can be found by visiting the company website at www.sambriapharma.com.